Tonix Pharmaceuticals Holding Corp. (TNXP) Institutional Ownership

Ownership Summary

According to SEC filings for the period ending September 2025, Tonix Pharmaceuticals Holding Corp. (NASDAQ:TNXP) is held by 58 institutional firms.

• The percentage of Tonix Pharmaceuticals Holding owned by institutions changed from 19.0% in June 2025 to 26.8% in September 2025, marking a slight up trend.
• On a quarter-over-quarter basis, institutional holdings shifted by 72.92%, with a year-over-year an increase of 93.33% in the count of filers.
• Among the 58 institutional holders of Tonix Pharmaceuticals Holding, 40 added to their stakes while 9 trimmed their positions and 9 held steady.
• Collectively, institutional investors increased their stake in Tonix Pharmaceuticals Holding to 2.35Mn shares as of September 2025, a change that is up by 989.13K shares quarter on quarter and up 1.32Mn shares year over year.
• BlackRock, Inc. continues to be the largest institutional holder of Tonix Pharmaceuticals Holding as of September 30, 2025, with a position of 681.53K shares, representing 7.77% of the company's outstanding stock.
• Among the most significant buyers of Tonix Pharmaceuticals Holding during September 2025 were VANGUARD GROUP INC (392.23K), BlackRock, Inc. (261.08K), CAPITAL FUND MANAGEMENT S.A. (62.95K), MILLENNIUM MANAGEMENT LLC (43.85K), FMR LLC (32.71K).
• Leading sellers of Tonix Pharmaceuticals Holding stock in September 2025 included Nuveen, LLC (36.52K), Tower Research Capital LLC (TRC) (3.71K), MORGAN STANLEY (3.25K), CITIGROUP INC (2.29K), BARCLAYS PLC (833).
• The top 10 institutional holders of Tonix Pharmaceuticals Holding for the quarter ending September 2025 included BlackRock, Inc. (681.53K), VANGUARD GROUP INC (556.96K), GEODE CAPITAL MANAGEMENT, LLC (200.93K), NORTHERN TRUST CORP (169.69K), STATE STREET CORP (152.54K), CAPITAL FUND MANAGEMENT S.A. (62.95K), MILLENNIUM MANAGEMENT LLC (52.73K), UBS Group AG (51.58K), FMR LLC (45.47K), Susquehanna Portfolio Strategies, LLC (41.45K).